Despite a steep Moderna stock crash this year, the longtime biotech executive has amassed a $4.6 billion fortune.
Photo/Agencies] Pfizer and BioNTech announced Monday that a third dose of their mRNA vaccine against COVID-19 was found to elicit a strong immune response for children 6 months to 5 years old. The ...
After months of delay, Pfizer has finally announced that they are seeking regulator approval for their COVID vaccine for ...
Pfizer-BioNTech’s new three-dose coronavirus vaccine for children under 5 years old is 80% effective at staving off infection ...
Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday.
Pfizer's COVID-19 vaccine produces a strong immune response in young children, preventing symptomatic infections at an 80.3% ...
The COVID-19 vaccine-maker Pfizer-BioNTech said Monday that its three-dose vaccine was about 80% effective in preventing ...
Other countries already have expanded Moderna's shot to kids as young as 6.While COVID-19 generally isn’t as dangerous to ...
Pfizer says three small doses of its COVID-19 vaccine protect kids under 5 and that it plans to give the data to U.S.
Pfizer says three small doses of its COVID-19 vaccine protect kids under 5 and that it plans to give the data to U.S.
PBS23h
Moderna Inc.’s leader said it is possible the company would be able to start shipping its Covid-19 vaccine for use in young ...